Cargando…
In vivo evaluation of integrin αvβ6-targeting peptide in NSCLC and brain metastasis
INTRODUCTION: Integrin αvβ6, which is upregulated in malignancies and remains absent or weak in normal tissue, is a promising target in molecular imaging therapeutics. In vivo imaging of integrin αvβ6 could therefore be valuable for early tumor detection and intraoperative guidance. METHODS: In this...
Autores principales: | Fan, Di, Zhang, Chengkai, Luo, Qi, Li, Baowang, Ai, Lin, Li, Deling, Jia, Wang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036820/ https://www.ncbi.nlm.nih.gov/pubmed/36968997 http://dx.doi.org/10.3389/fonc.2023.1070967 |
Ejemplares similares
-
Targeting integrin α5β1 in urological tumors: opportunities and challenges
por: Zhou, Xuming, et al.
Publicado: (2023) -
Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells
por: Phanthaphol, Nattaporn, et al.
Publicado: (2021) -
Integrin α6β4 signals through DNA damage response pathway to sensitize breast cancer cells to cisplatin
por: Chen, Min, et al.
Publicado: (2022) -
Promotion of Bone Lesions Through the Myeloma Integrin α6-Mediated Osteolytic Signaling
por: Liu, Huan, et al.
Publicado: (2021) -
SPECT/CT Imaging, Biodistribution and Radiation Dosimetry of a (177)Lu-DOTA-Integrin αvβ6 Cystine Knot Peptide in a Pancreatic Cancer Xenograft Model
por: Sachindra, Sachindra, et al.
Publicado: (2021)